ERdj3/DNAJB11 is an endoplasmic reticulum (ER)-targeted HSP40 co-chaperone that performs multifaceted functions involved in coordinating ER and extracellular proteostasis. Here, we show that ERdj3 assembles into a native tetramer that is distinct from the dimeric structure observed for other HSP40 co-chaperones. An electron microscopy structural model of full-length ERdj3 shows that these tetramers are arranged as a dimer of dimers formed by distinct inter-subunit interactions involving ERdj3 domain II and domain III. Targeted deletion of residues 175-190 within domain II renders ERdj3 a stable dimer that is folded and efficiently secreted from mammalian cells. This dimeric ERdj3 shows impaired substrate binding both in the ER and extracellular environments and reduced interactions with the ER HSP70 chaperone BiP. Furthermore, we show that overexpression of dimeric ERdj3 exacerbates ER stress-dependent reductions in the secretion of a destabilized, aggregation-prone protein and increases its accumulation as soluble oligomers in extracellular environments. These results reveal ERdj3 tetramerization as an important structural framework for ERdj3 functions involved in coordinating ER and extracellular proteostasis in the presence and absence of ER stress.
Introduction
The HSP70 chaperoning pathway functions to regulate proteostasis through a highly conserved mechanism involving ATP-dependent regulation of HSP70 binding to protein substrates (Kampinga & Craig, 2010; Kim et al, 2013; Cyr & Ramos, 2015; . Mammals encode 11 HSP70 chaperones that localize to distinct intracellular environments including the cytosol, nucleus, mitochondria, and the endoplasmic reticulum (ER). These HSP70 chaperones are involved in diverse proteostasis functions including protein folding, protein degradation, protein disaggregation, translocation of polypeptides across membranes, and the regulation of stress-responsive signaling pathways (Kampinga & Craig, 2010; Kim et al, 2013; Cyr & Ramos, 2015; . This functional diversity is primarily mediated through a network of HSP40 co-chaperones similarly localized throughout mammalian cells. HSP40s predominantly function by engaging misfolded protein substrates and delivering them to HSP70 for ATP-dependent chaperoning (Kampinga & Craig, 2010; Kim et al, 2013; Cyr & Ramos, 2015; . Through this basic mechanism, HSP40 co-chaperones can influence many aspects of HSP70 function including client specificity, disaggregase activity, localization, and ATPase activity.
HSP40 co-chaperones are classified into three categories based on similarity to the domain architecture of the E. coli HSP40 DNAJ (Kampinga & Craig, 2010) . Type I HSP40 co-chaperones have a conserved structure containing an N-terminal J-domain, a Gly/Phe flexible region, a bifurcated substrate binding domain separated by a zinc finger domain, and a C-terminal dimerization domain. Type II HSP40 co-chaperones are similar to Type I, although the zinc finger domain is replaced with a variable domain II. In contrast, Type III HSP40 co-chaperones are highly diverse, but contain a J-domain. Type I and Type II HSP40s generally assemble and function as dimers formed by inter-subunit interactions between the C-terminal dimerization domains (Kampinga & Craig, 2010; Alderson et al, 2016) . Dimerization has previously been shown to be important for critical HSP40 functions including binding to misfolded protein substrates (Wu et al, 2005; Otero et al, 2014) . However, these HSP40 dimers can vary in structure despite having similar domain organizations, potentially providing unique structural frameworks to allow for the many functions of HSP40 co-chaperones (e.g., dictating HSP70 client specificity; Sha et al, 2000; Borges et al, 2005; Wu et al, 2005; Hu et al, 2008; Ramos et al, 2008) . HSP40 dimers can also transiently assemble into higher order oligomers in the presence of protein aggregates to promote disaggregation .
Seven different HSP40 co-chaperones localize to the ER and regulate the folding, trafficking, or degradation of the secretory proteome (Kampinga & Craig, 2010; Otero et al, 2010; Melnyk et al, 2015) . Of these ER HSP40s, one of the most abundant is the soluble Type II HSP40 co-chaperone ERdj3/DNAJB11. ERdj3 has diverse functions involved in coordinating ER and extracellular proteostasis. In the ER, ERdj3 functions as a canonical HSP40 co-chaperone, binding to misfolded proteins and delivering them to the ER HSP70 BiP for ATP-dependent chaperoning (Shen et al, 2002; Shen & Hendershot, 2005; Jin et al, 2009; Marcinowski et al, 2011; Guo & Snapp, 2013; Behnke et al, 2016) . Through this mechanism, ERdj3 functions to regulate the folding or degradation of secretory proteins including immunoglobulin light and heavy chains, the epithelial sodium channel, and glucocerebrosidase (Shen & Hendershot, 2005; Jin et al, 2009; Buck et al, 2010; Tan et al, 2014) . In addition, ERdj3 is involved in regulating ER permeability and protein translocation into the ER through interaction with the Sec61 translocon (Dejgaard et al, 2010; Guo & Snapp, 2013; Schorr et al, 2015) . However, in response to ER stress, ERdj3 is secreted to the extracellular space where it functions as an ATP-independent extracellular chaperone to prevent the misfolding and/or aggregation of secreted proteins . ERdj3 can also preemptively protect extracellular proteostasis through co-secretion in a complex with destabilized, aggregation-prone proteins in a process regulated by BiP availability . Through these mechanisms, ERdj3 functions to protect the extracellular environment from misfolded, aggregation-prone proteins that can be secreted during ER stress . Thus, ERdj3 functions in both ATP-dependent HSP70 chaperoning and ATP-independent extracellular chaperoning to coordinate regulation between ER and extracellular proteostasis environments. ERdj3 can also function as an extracellular signaling molecule to regulate integrin signaling, indicating additional functions for secreted ERdj3 (Wang et al, 2013; Lee et al, 2016) .
A key question is what are the structural features of ERdj3 required for its role in coordinating ER and extracellular proteostasis? The domain architecture of ERdj3 is similar to other Type I and Type II HSP40 co-chaperones (Jin et al, 2009; Kampinga & Craig, 2010) and includes an N-terminal J-domain, a Gly/Phe-rich linker, a bifurcated substrate binding domain separated by a Cys-rich domain II containing two disulfide bonds, and a C-terminal dimerization domain III (Fig 1A) . ERdj3 is predicted to adopt a dimeric structure formed by inter-subunit interactions between the ERdj3 dimerization domain III-a structure similar to that observed in other HSP40 co-chaperones (Kampinga & Craig, 2010; Alderson et al, 2016) . Mutations within ERdj3 domain III can render ERdj3 monomeric and impair substrate-binding activity (Jin et al, 2009; Otero et al, 2014) . Substrate binding can also be impaired through mutations in the substrate-binding domain (Jin et al, 2009) . In contrast, the ERdj3 J-domain is required for functional interactions with BiP, but is not required for ERdj3 substrate binding or ATP-independent chaperoning activity (Otero et al, 2014) . Interestingly, the Cys-rich ERdj3 domain II appears to have important roles for dictating both ERdj3 substrate binding and stability. Disruption of the domain II disulfide bonds reduces its binding to substrates and is predicted to destabilize ERdj3 (Marcus et al, 2007) . Similarly, complete deletion of ERdj3 domain II inhibits ERdj3 chaperoning activity and decreases the intracellular half-life of ERdj3 (Jin et al, 2009) .
Here, we employ biochemical and structural approaches to define the ERdj3 quaternary structure. Surprisingly, we show that ERdj3 assembles into a native tetramer stabilized by distinct intersubunit interactions involving its dimerization domain III and the 
Results
Gel filtration and analytical ultracentrifugation show that endogenous and recombinant ERdj3 WT assemble into tetramers
ERdj3 is a multi-domain protein with a well-defined domain architecture ( Fig 1A) . ERdj3 is homologous to other canonical Type II HSP40 co-chaperones such as DNAJB1/Hdj1 (Appendix Fig S1A) .
Crystal structures of DNAJB1 and other HSP40 co-chaperones lacking their N-terminal J-domain have revealed that these proteins dimerize through inter-subunit contacts between their dimerization domain III (Appendix Fig S1B; Sha et al, 2000; Borges et al, 2005; Wu et al, 2005; Hu et al, 2008; Ramos et al, 2008) . This led to speculation that ERdj3 also assembles into a dimer through its dimerization domain III (Fig 1B) . In order to test this prediction, we used gel filtration chromatography to determine the size of overexpressed wild-type ERdj3 (ERdj3 WT ) secreted from transfected HEK293T cells. Surprisingly, secreted ERdj3
WT eluted with fractions that corresponded to a molecular weight of~146 Da, which is significantly higher than the predicted 76 kDa dimer ( Fig 1C) (Jin et al, 2009; Otero et al, 2014) . We next probed the oligomeric state of R ERdj3 WT using an in vitro crosslinking assay. Increasing concentrations of three different lysine crosslinking reagents (DSP, DSS, and EGS) show stabilization of an ERdj3 oligomer of~150 kDa, which is consistent with the 153 kDa ERdj3 tetramer (Appendix Fig S1C) . These oligomers were further defined using analytical ultracentrifugation (AUC (Fig 1D, Appendix Fig S1D) . Using a frictional coefficient of 1.5, which is similar to that previously calculated for the HSP40 co-chaperone Sis1 and takes into account the elongated structure of HSP40 co-chaperones (Silva et al, 2011) (Figs 2A and EV1A) . Subsequent 3D reconstruction of these data yielded a 19 Å resolution structure, which reveals ERdj3 as a tetramer organized as a "dimer of dimers" (Figs 2B and EV1B and C) . The structure comprises 4 tube-like densities of similar length, with two distinct types of vertices responsible for connecting these 4 densities (Fig 2B and C) . Four globular densities localize above and below the diamond, which appear to be flexible domains that are independent of the core dimer or dimers structure. Unfortunately, the high degree of conformational flexibility of R ERdj3 WT , which hinders structure determination by crystallography, also prevents higher resolution structure determination by EM. In an attempt to reduce this conformational flexibility, we performed an analogous EM analysis of R
ERdj3
WT in the presence of a substrate:
the monomeric variant of transthyretin (M-TTR). We confirmed that R ERdj3 WT binds M-TTR by co-immunopurification ( Fig EV1D) .
However, in the presence of M-TTR, R ERdj3 WT remained in a flexible tetrameric conformation, demonstrating that the presence of substrate does not influence ERdj3 tetramerization or reduce conformational flexibility ( Fig EV1E) . In order to determine the domain organization of Fig S1A) , suggesting that this second interface may be mediated through inter-subunit contacts between the elongated R ERdj3 WT domain II.
Our EM structure was determined using full-length R ERdj3 WT , which includes the J-domains that are normally removed for structure determination. This allows us to define the organization of the J-domains within the ERdj3 tetramer. Based on the docking of DNAJB1 DJ into our R ERdj3 WT model, the globular structures localized above the core ERdj3 diamond likely represent the J-domain of this full-length protein ( Fig 2C) . The size of these globular structures is consistent with the size of crystallized J-domains ( Fig EV1F) . Furthermore, a crosslinking-mass spectrometric analysis of R ERdj3 WT using a low concentration of the lysine reactive crosslinker DSS reveals multiple crosslinks between peptides comprising the J-domain and other ERdj3 domains including the substrate binding domain and the dimerization domain, indicating that the J-domain is available to interact with multiple parts of the protein ( Fig EV1G) . These results indicate that the J-domain is highly flexible and localizes above (or below) the core ERdj3 tetramer, providing a dynamic surface to form functional interactions with the ER HSP70 chaperone BiP.
Targeted deletion in ERdj3 domain II disrupts formation of the native tetramer
Our EM reconstruction indicates that the unique tetramerization interface of ERdj3 is mediated through domain II inter-subunit interactions. This domain contains 4 Cys residues that form stabilizing disulfide bonds important for ERdj3 stability and function (Marcus et al, 2007) . Non-reducing SDS-PAGE/immunoblotting shows that these disulfides are intramolecular (Marcus et al, 2007) , indicating that the tetramerization interface predicted for domain II is not mediated through inter-subunit disulfide bond formation. Interestingly, secondary structure prediction software including PSIPRED (Jones, 1999; Buchan et al, 2013) identified two potential b-sheets separated by a turn that localize between the two pairs of cysteine residues within ERdj3 domain II ( Fig 3A) . These same b-sheets were predicted in previous structural models of ERdj3 domain II (Jin et al, 2009) . The presence of this structural motif suggests it may be important for dictating ERdj3 tetramerization through domain II inter-subunit contacts identified by EM. We defined the importance for domain II in ERdj3 tetramerization by monitoring the oligomeric state of ERdj3 mutants secreted from mammalian cells using gel filtration. We collected conditioned media from HEK293T cells transfected with ERdj3 mutants including the J-domain mutant ERdj3 , containing mutations predicted to disrupt the b-sheets within domain II. Initially, we confirmed that these ERdj3 variants are secreted to conditioned media using immunoblotting. We previously showed that ERdj3 H53Q is efficiently secreted from mammalian cells . All of the other ERdj3 variants also accumulate in conditioned media, reflecting efficient secretion from cells (Figs 3C and EV2B A Protein sequence for the ERdj3 domain II (residues 160-200) including a sheet-turn-sheet structural motif within this sequence predicted using the PSIPRED algorithm (Jones, 1999; Buchan et al, 2013) . The two predicted b sheets are shown by the purples arrows. The Cys residues that form stabilizing disulfides are also shown (red (Figs 3C and EV2C) . This shows that overexpression of these ERdj3 variants induces a moderate amount of ER stress, likely through the presence of the unstructured b-sheet in domain II (Fig 3A) . However, none of the ERdj3 mutants influence ERSE.FLuc activation in the presence of the ER stressor thapsigargin (Tg), indicating that these ERdj3 variants do not disrupt ER stress induced UPR activation. We used gel filtration chromatography to compare the size of secreted ERdj3 variants in conditioned media. The secreted J-domain mutant ERdj3 H53Q elutes at an identical size to that observed for ERdj3 WT , indicating that this mutation does not influence ERdj3 oligomerization (Fig EV2D) . In contrast, secreted
ERdj3
F326D elutes at much later fractions that correspond to the monomeric molecular weight of 38 kDa (Fig EV2D) . This is consistent with previous work showing this point mutation ablates ERdj3 oligomerization (Jin et al, 2009; Otero et al, 2014) Kai
WT , indicating that these mutants do not globally disrupt the ERdj3 secondary structure (Appendix Fig S2A) . Gel filtration of R
DII and R ERdj3 QEVV shows that these proteins elute with a peak fraction consistent with dimeric ERdj3 (Fig 4B) and identical to those observed for secreted ERdj3 DII and ERdj3 QEVV (Fig 3D) . (Fig 4C and D, and Appendix Fig S2B and C) 
DII aggregates into high molecular weight oligomers ( Fig EV2D) . We further demonstrated the importance of domain II for ERdj3 tetramerization by crosslinking R ERdj3 QEVV with different lysine crosslinking reagents, all of which predominantly result in formation of ERdj3 dimers (Appendix Fig S2D) .
The results shown in Figs 3 and 4 demonstrate that ERdj3 tetramerization requires inter-subunit interactions between domain II. Interestingly, domain II is highly variable across other human Type I and II HSP40 co-chaperones (Kampinga & Craig, 2010) , suggesting that other HSP40 co-chaperones are unlikely to form the same tetramerization interface used by ERdj3. However, the ERdj3 domain II is conserved across multicellular organisms, although it is divergent from the cytosolic yeast homolog YDJ1 (Appendix Fig  S2E) . This suggests that ERdj3 tetramerization may have evolved to perform chaperoning activities important for multicellular organisms, such as the coordination of ER and extracellular proteostasis environments.
Targeted disruption of domain II decreases ERdj3 substrate binding
ERdj3 regulates proteostasis throughout the secretory pathway . In the ER, ERdj3 functions as a canonical HSP40 co-chaperone by binding misfolded proteins and delivering these proteins to BiP for ATPdependent chaperoning. However, in response to ER stress, ERdj3 can be secreted to the extracellular space either alone or in complex with non-native substrates to protect the extracellular environment from destabilized, aggregation-prone proteins that can aggregate into toxic oligomers and amyloid fibrils . Here, we define how targeted deletion within domain II influences ERdj3 functions important for regulating proteostasis throughout the secretory pathway.
We used an immunopurification (IP) approach to define how targeted deletion within ERdj3 domain II influences functional interactions with BiP (Kampinga & Craig, 2010; . We co-expressed FLAG-tagged BiP ( (Fig 5A and B) . However, the ERdj3 H53Q mutation disrupts functional interactions with BiP, reflected by the decreased recovery of ERdj3 H53Q in FT BiP IPs. This is consistent with previous results (Shen & Hendershot, 2005 does not demonstrate reduced association with BiP, potentially reflecting that BiP recognizes this monomeric mutant as a client (Fig 5A and B) .
Next, we defined how targeted deletion within ERdj3 influences intracellular binding to substrates such as the non-secreted, destabilized D18G TTR mutant (TTR D18G ). We co-overexpressed ERdj3 mutants and FLAG-tagged TTR D18G (   FT   TTR   D18G ) in HEK293T cells and performed an identical co-IP approach to that described above.
Overexpressed ERdj3
WT is efficiently recovered in FT TTR D18G IPs, confirming this protein as an ERdj3 substrate (Fig 5C and D WT . Error bars represent standard error for n = 3. *P < 0.05. **P < 0.01 from a paired t-test.
E Representative immunoblot of secreted ERdj3
WT or ERdj3 QEVV from conditioned media collected from transfected HEK293T cells purified using an affinity Sepharose resin conjugated to native or denatured RNase A. Conditioned media containing ERdj3 WT or ERdj3 QEVV are shown as input.
F Bar graph depicting quantification of secreted ERdj3
WT and ERdj3 QEVV mutants associated with denatured RNase A beads as in (E). Data are normalized to ERdj3 WT . Error bars represent standard error for n = 3. *P < 0.05 from a paired t-test.
Source data are available online for this figure. (Fig EV3A and B) . These results indicate that disruption of the ERdj3 tetramer through targeted disruption of domain II or mutation in the dimerization domain decreases ERdj3 substrate binding.
We next sought to determine how targeted deletion within domain II influences the binding of secreted ERdj3 to non-native protein conformations in extracellular environments . For these experiments, we employed Sepharose beads conjugated to native or denatured RNase A. We then incubated these beads with either recombinant or cell-secreted ERdj3 QEVV and monitored interactions by co-purification and immunoblotting. We previously used this exact assay to show that secreted ERdj3 WT and ERdj3 H53Q selectively bind non-native protein substrates . ). ERdj3 binds to FT TTR A25T in the ER and extracellular environments (Shoulders et al, 2013; . In addition, FT TTR A25T secretory proteostasis is highly sensitive to ER stress . Tg-induced ER stress decreases secretion of total FT TTR A25T (Shoulders et al, 2013) and increases the extracellular population of FT TTR A25T that accumulates as soluble aggregates commonly associated with human disease . We then collected conditioned media from these cells in the absence or presence of Tg. All conditioned media was prepared in the presence of the non-cellpermeable small molecule Tafamidis-Sulfonate (Taf-S). Taf-S is a kinetic stabilizer of the native FT 
TTR
A25T tetramer that selectively stabilizes tetrameric TTR only upon secretion to the extracellular space . The addition of Taf-S during conditioning allows quantification of the population of FT TTR A25T secreted in non-native conformations that accumulate in the extracellular space as soluble aggregates . Initially, we quantified total FT TTR A25T (including stabilized tetramers and soluble aggregates) that accumulate in these conditioned media using SDS-PAGE/immunoblotting (Fig 6A) . In the absence of Tg, we do not observe significant differences in the amounts of total , preventing its ability to function as a dominant negative to suppress endogenous ERdj3 activity during ER stress. Regardless, our results show that disruption of the ERdj3 tetramer through targeted deletions within domain II significantly decreases the capacity for ERdj3 to regulate secretory proteostasis in response to ER stress, highlighting the importance of domain II-dependent ERdj3 tetramerization for maintaining the integrity of the secretory proteome during conditions of ER stress.
Discussion
Here, we show that ERdj3 assembles as a native tetramer formed by distinct inter-subunit interactions involving domain II and tetramerization is a key structural feature important for ERdj3-dependent coordination of proteostasis throughout the secretory pathway. Our identification of ERdj3 as a homo-tetramer is supported by previous biochemical observations indicating that ERdj3 behaves as a protein substantially larger than the predicted dimer. Native gel electrophoresis previously showed that ERdj3 migrates as an 
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The EMBO Journal oligomer with a molecular weight of~200 kDa, which is substantially larger than the predicted dimer and more consistent with an ERdj3 tetramer (Guo & Snapp, 2013) . Furthermore, fluorescence recovery after photobleaching experiments shows that ERdj3 diffuses in the ER at rates slower than those predicted for the ERdj3 dimer (Guo & Snapp, 2013) . This slower diffusion likely reflects interactions between ERdj3 and ER proteostasis factors including Sec61 and an ER-localized multi-protein chaperoning complex Dejgaard et al, 2010; Guo & Snapp, 2013 Tetramerization of ERdj3 may also provide a template to differentially influence the folding, degradation, or aggregation of structurally distinct client proteins in the ER or extracellular environments. Interactions with ERdj3 have been shown to distinctly impact the fate of ER or extracellular substrates. In the ER, ERdj3 promotes BiP-dependent folding, inhibits the aggregation, and/or reduces the degradation of ER-targeted proteins such as immunoglobulin heavy and light chain (Shen & Hendershot, 2005; Kampinga & Craig, 2010; Behnke et al, 2016) . However, ERdj3 has also been proposed to promote the degradation of proteins such as the epithelial sodium channel and destabilized glucocerebrosidase variants (Buck et al, 2010; Tan et al, 2014) . The presence of four substrate-binding sites in a single ERdj3 tetramer could allow for multiple interactions with distinct hydrophobic regions of a client protein or complex. These types of multivalent interactions between ERdj3 and substrates could potentially stabilize a specific conformation that promote targeting to folding or degradation pathways (e.g., BiP chaperoning pathway and ER-associated degradation, respectively) or inhibit aggregation into toxic oligomeric conformations. Currently, the ability for an HSP40 co-chaperone to influence targeting of a substrate toward folding or degradation through this type of mechanism has not been demonstrated. However, the ATP-independent secreted chaperones clusterin can stabilize small oligomeric conformations of amyloidogenic proteins such as Ab, preventing their further aggregation into toxic oligomers or amyloid fibrils (Narayan et al, 2012) . ERdj3 tetramers may similarly stabilize small oligomeric conformations of amyloidogenic proteins through multiple interactions with its four substrate binding domains, providing a mechanism to explain the substoichiometric inhibition of protein aggregation observed for ERdj3 .
ERdj3 tetramerization could also influence substrate fate by providing a structural template to modulate functional interactions between ERdj3 and other proteostasis pathways. In the ER, ERdj3 forms functional interactions with Sec61 and the ER HSP70 BiP (Dejgaard et al, 2010; Guo & Snapp, 2013; Otero et al, 2014; Schorr et al, 2015) . In addition, ERdj3 has also been shown to incorporate into a multi-chaperone complex including many other ER proteostasis factors including GRP94, HYOU1, PDI, and UDPglucosyltransferase in the presence of substrates such as immunoglobulin heavy chain . ERdj3 tetramers increase binding sites on this co-chaperone, which could increase the capacity to form interactions with one or several of these interaction partners. Specific ERdj3 domains important for interacting with many of these ER proteostasis factors remain currently undefined. However, our results show that ERdj3 interactions with the ER HSP70 chaperone BiP are impaired in the dimeric ERjd3
QEVV mutant, suggesting tetramerization may be important for interactions with functional partners. ERdj3 tetramerization could also serve an important role for dictating nonproteostasis interactions between ERdj3 and cellular factors involved in other functions such as integrin signaling (Wang et al, 2013; Lee et al, 2016) . The importance of ERdj3 tetramerization for integrin signaling could potentially reflect the emergence of domain II sequence conservation in multi-cellular organisms where this type of signaling is observed. To our knowledge, our results identify ERdj3 as the first type I or type II HSP40 co-chaperone to assemble into a native tetramer, as opposed to the dimeric structure observed for most HSP40 cochaperones of these types. As discussed above, the formation of the tetramer provides a unique structural framework to define how ERdj3 coordinates its diverse functions involved in regulating ER and extracellular proteostasis. In addition, our identification of residues 175-190 of domain II as the key determinants in ERdj3 tetramerization provides new insights into the importance of domain II for ERdj3 function and reveals potential mechanisms to regulate ERdj3 substrate binding and proteostasis regulation through posttranslational alterations targeting this domain. BiP plasmids were transfected using the calcium phosphate transfection method. The transfected cells were incubated overnight before harvesting. Lysate was prepared in the lysis buffer (20 mM HEPES pH 7.0, 150 mM NaCl, 1% Triton X-100, 5 mM EDTA) plus cOmplete â protease inhibitor cocktail (Roche).
Materials and Methods
For immunoprecipitation with the FLAG-tagged constructs following crosslinking, the harvested cells were resuspended in DPBS (Gibco), and 1 mM DSP was added to the suspension from 100 mM stock in DMSO. The cells were incubated at ambient temperature for 30 min, and 100 mM Tris pH 8.0 was added to quench the reaction for another 15 min. The cells were then lysed as described above for immunoprecipitation with M2 anti-FLAG magnetic beads (Sigma) overnight at 4°C. The beads were washed four times in RIPA buffer before elution by boiling in 3× SDS loading buffer without DTT. 100 mM DTT was added to the eluents, and the sample was boiled again before SDS-PAGE and Western blot. After overnight primary antibody incubation at 4°C, the blots were incubated with IR Dye conjugated secondary antibodies (LICOR) and the quantified with the Odyssey system (LICOR). ERdj3 variant using calcium phosphate. Cells were then cultured overnight in cell culture media containing 10 lM Tafamidis-Sulfonate (Taf-S). Thapsigargin (Tg; 500 nM) was added as indicated. Conditioned media was then collected and analyzed by SDS-PAGE/ immunoblotting and Clear-Native-PAGE/immunoblotting, as previously described (Chen et al, 2014 . The relative amounts of total or aggregate FT TTR A25T were quantified with the Odyssey system (LICOR).
Conditioned media analytical gel filtration chromatography
Conditioned media sample was first passed through 0.22 lm filter to remove insoluble species. Then, 500 ll of sample was injected onto a self-packed Superdex 200 (GE Healthcare) analytical column (10 × 300 mm) using the Ä KTA FPLC system at flow rate of 0.4 ml/ min. 1× DPBS (Gibco) was used as the mobile phase at ambient temperature. The column was calibrated with NativeMark ™ Unstained Protein Standard (Life Technology). The fractions were collected with interval of 1 ml and analyzed by SDS-PAGE and Western blot.
R
ERdj3 purification and characterization 6xHis Smt3 tagged ERdj3 mutants were transformed into SHuffle â T7 Express competent E. coli (NEB) and incubated at 30°C. The overnight culture grown at 30°C in LB media was inoculated in LB media at ratio of 1:1,000 to grow at 30°C till O.D. reaches~0.6, and then, 0.1 mM IPTG was used to induce overnight expression at 25°C. The harvested cells were sonicated in Ni A buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 20 mM imidazole) with cOmplete ™ Ultra EDTA free protease inhibitor (Roche). The lysate was centrifuged and then filtered through 0.45 lm filter before loading onto HisTrap FF column (GE Healthcare) using Ä KTA FPLC system (GE Healthcare). The column was washed with 5% Ni B buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 250 mM imidazole) before eluted with 100% Ni B buffer. The eluents was dialyzed overnight at 4°C in Ni A buffer with ULP1 protease added to cleave the 6xHis Smt3 tag. The sample was then loaded onto HisTrap column to collect untagged R ERdj3 in the flow through. Next, the concentrated sample was loaded onto Superdex 200 prep grade column (GE Healthcare, self-packed) in HN buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol). The collected fractions were concentrated and flash-frozen to be stored at À80°C. For circular dichroism analysis, the proteins were dialyzed overnight in 50 mM Na Pi pH 7.5, 300 mM NaCl, 10% glycerol at 4°C. The dialyzed sample was diluted to 6 lM, and CD measurements were made with an Aviv 62A DS Circular Dichroism spectrometer, using quartz cuvettes with a 0.2 cm path length. CD spectra were obtained by monitoring molar ellipticity from 260 to 200 nm, with 10-s averaging times.
Analytical ultracentrifugation and velocity data analysis

Recombinant ERdj3
WT and mutants were dialyzed overnight at 4°C in 50 mM HEPES pH 7.5, 300 mM NaCl to remove glycerol. The dialyzed samples were then diluted to final concentrations and run at 201,600 g with Beckman Optima XL-I Analytical Ultracentrifuge. Sedimentation velocity data were collected using UV absorbance at 280 nm every 10 min for up to 600 cycles. The buffer density (1.0144 g/ml), viscosity ( 0.7346) were calculated using the Sednterp program. The sedimentation velocity data were fit using continuous distribution C(s) model with SedFit. The apparent s values of each run were obtained from the integration of the C(s) peak and corrected it to standard condition s 20,w of using SedFit. The s distribution and residue maps were plotted using the GUSSI program (Brautigam, 2015) by importing the data from SedFit. The s 20,w data were extrapolated linearly to concentration of 0 mg/ml to obtain s 0 20;w reported in the text, and the error represents the standard deviation of peak value. The molecular weights of each mutant were calculated using SedFit with s value at 0 mg/ml and f/f 0 ratio of 1.5.
RNase A beads assay
RNase A-conjugated beads were incubated in 20 mM Tris, pH 8.8, 6 M guanidinium hydrochloride, and 100 mM dithiothreitol overnight to disrupt the disulfide bonds in RNase A. The denatured and reduced RNase A beads were then incubated in 100 mM Tris, pH 8, and 37.5 mM iodoacetamide to block free thiols, thus preventing RNase A from adopting its native structure. 
